Literature DB >> 18311435

IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris.

Wojciech Baran1, Jacek C Szepietowski, Grzegorz Mazur, Eugeniusz Baran.   

Abstract

Overexpression of IL-6 has been implicated in the pathology of numerous autoimmune and chronic inflammatory diseases, including psoriasis, and relative deficiency of IL-10 in psoriatic patients seems to be important in the development of this disease. The aim of this study was to investigate the association between IL-6 and IL-10 single nucleotide polymorphisms and susceptibility to psoriasis vulgaris. DNA from 78 patients with psoriasis vulgaris and 74 healthy volunteers was investigated. IL-6 promoter gene single nucleotide polymorphisms in position -174, and IL-10 single nucleotide polymorphisms in positions -1082, -819 and -592 were evaluated by polymerase chain reaction using sequence-specific primers. No significant differences were found in the polymorphisms of IL-6 and IL-10 promoter genes between patients with psoriasis and healthy controls.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18311435     DOI: 10.2340/00015555-0427

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  12 in total

1.  Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Inflamm Res       Date:  2012-03-18       Impact factor: 4.575

2.  Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia--a case-control study.

Authors:  Monika Paul-Samojedny; Malgorzata Kowalczyk; Renata Suchanek; Aleksander Owczarek; Anna Fila-Danilow; Aleksandra Szczygiel; Jan Kowalski
Journal:  J Mol Neurosci       Date:  2010-09       Impact factor: 3.444

3.  Interleukin-6 and interleukin-10 gene promoter polymorphisms and risk of endemic Burkitt lymphoma.

Authors:  Cliff I Oduor; Kiprotich Chelimo; Collins Ouma; David H Mulama; Joslyn Foley; John Vulule; Jeffrey A Bailey; Ann M Moormann
Journal:  Am J Trop Med Hyg       Date:  2014-07-28       Impact factor: 2.345

Review 4.  IL-6 as a druggable target in psoriasis: focus on pustular variants.

Authors:  Andrea Saggini; Sergio Chimenti; Andrea Chiricozzi
Journal:  J Immunol Res       Date:  2014-07-13       Impact factor: 4.818

Review 5.  The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs' activation and function.

Authors:  Bogusław Nedoszytko; Małgorzata Sokołowska-Wojdyło; Joanna Renke; Magdalena Lange; Piotr Trzonkowski; Michał Sobjanek; Aneta Szczerkowska-Dobosz; Marek Niedoszytko; Aleksandra Górska; Jan Romantowski; Jarosław Skokowski; Leszek Kalinowski; Roman J Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2017-12-31       Impact factor: 1.837

6.  Lack of association of the IL-1RN and IL-10 polymorphisms with risk of psoriasis: A meta-analysis.

Authors:  Ju Qiao; Qian-Nan Jia; Hong-Zhong Jin
Journal:  Mol Genet Genomic Med       Date:  2018-12-06       Impact factor: 2.183

7.  Sleep loss and cytokines levels in an experimental model of psoriasis.

Authors:  Camila Hirotsu; Mariana Rydlewski; Mariana Silva Araújo; Sergio Tufik; Monica Levy Andersen
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 8.  Genetics of psoriasis and pharmacogenetics of biological drugs.

Authors:  Rocío Prieto-Pérez; Teresa Cabaleiro; Esteban Daudén; Dolores Ochoa; Manuel Roman; Francisco Abad-Santos
Journal:  Autoimmune Dis       Date:  2013-08-28

9.  Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut.

Authors:  David Groeger; Liam O'Mahony; Eileen F Murphy; John F Bourke; Timothy G Dinan; Barry Kiely; Fergus Shanahan; Eamonn M M Quigley
Journal:  Gut Microbes       Date:  2013-06-21

Review 10.  Genetic polymorphism in psoriasis and its meaning for the treatment efficacy in the future.

Authors:  Agnieszka Osmola-Mańkowska; Ewa Teresiak-Mikołajczak; Marzena Skrzypczak-Zielińska; Zygmunt Adamski
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.